Sling begins subject enrolment in Phase IIb thyroid eye disease trial
The trial will analyse the safety, pharmacokinetics and efficacy of orally twice a day dose of linsitinib in TED patients.
Canada
Latest in
Canada
Cybin completes purchase of anxiety disorder treatment study
The acquisition is expected to accelerate clinical development pathway of CYB004 by nine months.
CIHR awards grant for COVID-19 Network of Clinical Trials Networks
The network will progress to support critical research capacity among a national network of over 60 sites with the funding.
Integrated research organisation Centricity merges with Aventiv
Through the merger with Aventiv, Centricity now provides CROs and sponsors access to 45 clinical trial sites.
AstraZeneca doses first subjects in Phase III lupus nephritis trial
The trial will assess the safety and efficacy of anifrolumab versus placebo in adults with active Class III or IV…
Zenith commences Phase IIb breast cancer combination therapy trial
The trial will analyse the safety and efficacy of ZEN-3694 plus Talzenna in germline wild type BRCA1/2 TNBC patients.
CCTG receives $30m Canadian Cancer Society grant to run clinical trials
The award will aid CCTG in supporting its key goals as well as the development and execution of trials.
Inversago begins dosing with INV-202 in Phase Ib metabolic syndrome trial
The trial will assess the safety profile and pharmacokinetics of INV-202 in patients with metabolic syndrome.